Global Health
Featured Topics
Lead story
Other featured articles
-
The Urgent Need for a New Generation of Antibiotics
Health policy experts discuss how to ensure the development of new antimicrobials to replace antibiotics and other critical medications that are beginning to lose their effectiveness.
Posted in -
Comparison of Catastrophic Out-of-Pocket Medical Expenditure Among Older Adults in the United States and South Korea: What Affects the Apparent Difference?
Medical spending rises sharply with age. Even with universal health insurance, older adults may be at risk of catastrophic out-of-pocket medical spending.
Posted in -
Global, Regional and National Trends in Statin Utilisation in High-Income and Low/Middle-Income Countries, 2015–2020
USC researchers examine recent trends and disparities in statin utilisation at the income group, regional and country levels.
Posted in -
Cannabis Regulations Inadequate Given Rising Health Risks of High-Potency Products
A new USC Schaeffer Center white paper shows how state-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.
Posted in
About this section
The Schaeffer Center’s impactful investigations reach worldwide to confront each nation’s unique issues, cultivating policies to promote healthier communities everywhere and access to care for everyone.
Our Experts On Global Health
Our Work In Global Health
-
Roe v. Wade: What Happens Next?
Join former Planned Parenthood President and CEO Faye Wattleton for a conversation about the history of Roe v. Wade and what a Supreme Court decision to overturn it might mean for women’s health, abortion access and our national political discourse.
-
Lifetime Exposure to Smoking, Epigenetic Aging, and Morbidity and Mortality in Older Adults
Scheffer Center experts examine how three epigenetic aging measures are associated with parental smoking, smoking in youth, and smoking in adulthood, and whether these epigenetic aging measures mediate the link between smoke exposure and morbidity and mortality.
Categorized in -
Rating the Comparative Efficacy of State-Level Cannabis Policies on Recreational Cannabis Markets in the United States
Schaeffer experts identified identified key cannabis policies and their provisions enacted by U.S. states; rated their theoretical efficacy in a restrictive form for reducing problematic use and impaired driving in the context of a recreational cannabis market as judged by experts; and rated the strength of evidence for each policy.
Categorized in -
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients
Schaeffer experts estimate the primary care prevalence of medical cannabis use according to confidential patient survey and to compare the prevalence of medical cannabis use documented in the EHR with patient report.
Categorized in -
Trends in the Use of Cannabis Products in Canada and the USA, 2018 – 2020: Findings From the International Cannabis Policy Study
There is little information on consumption patterns across the diverse range of cannabis product types. This paper examines trends in consumption patterns in Canada and the United States (US) between 2018-2020.
Categorized in -
Shifting the Demand for Vaccines: A Review of Strategies
Vaccines prevent millions of deaths, and yet millions of people die each year from vaccine-preventable diseases. The primary reason for these deaths is that a significant fraction of the population chooses not to vaccinate.
Categorized in